Cargando…

Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells

Adoptive cell therapy (ACT) using chimeric antigen receptor (CAR) T cells holds impressive clinical outcomes especially in patients who are refractory to other kinds of therapy. However, many challenges hinder its clinical applications. For example, patients who undergo chemotherapy usually have an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Netsrithong, Ratchapong, Wattanapanitch, Methichit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505955/ https://www.ncbi.nlm.nih.gov/pubmed/34650571 http://dx.doi.org/10.3389/fimmu.2021.759558

Ejemplares similares

Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells
por: Netsrithong, Ratchapong, et al.
Publicado: (2020)

Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders
por: Wattanapanitch, Methichit
Publicado: (2019)

A precise gene delivery approach for human induced pluripotent stem cells using Cas9 RNP complex and recombinant AAV6 donor vectors
por: Chupradit, Koollawat, et al.
Publicado: (2022)

Analysis of Influenza A virus infection in human induced pluripotent stem cells (hiPSCs) and their derivatives
por: Ruangrung, Kanyarat, et al.
Publicado: (2022)

Dual Small-Molecule Targeting of SMAD Signaling Stimulates Human Induced Pluripotent Stem Cells toward Neural Lineages
por: Wattanapanitch, Methichit, et al.
Publicado: (2014)

A three-dimensional immune-oncology model for studying in vitro primary human NK cell cytotoxic activity
por: Thongsin, Nontaphat, et al.
Publicado: (2022)

Endothelial Progenitor Cell Migration-Enhancing Factors in the Secretome of Placental-Derived Mesenchymal Stem Cells
por: Kamprom, Witchayaporn, et al.
Publicado: (2016)

Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases
por: Tanaka, Takayuki, et al.
Publicado: (2022)

Induced Pluripotent Stem Cell (iPSC)–Derived Lymphocytes for Adoptive Cell Immunotherapy: Recent Advances and Challenges
por: Nianias, Alexandros, et al.
Publicado: (2019)

The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives
por: Liu, Xin, et al.
Publicado: (2017)

Neoantigen Specific T Cells Derived From T Cell-Derived Induced Pluripotent Stem Cells for the Treatment of Hepatocellular Carcinoma: Potential and Challenges
por: Lu, Fei, et al.
Publicado: (2021)

Adoptive T Cell Therapy Following Haploidentical Hematopoietic Stem Cell Transplantation
por: Zhang, Ping, et al.
Publicado: (2019)

Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells
por: Benabdallah, Basma, et al.
Publicado: (2019)

Induced Pluripotent Stem Cell-Based Cancer Vaccines
por: Ouyang, Xiaoming, et al.
Publicado: (2019)

Immunosuppressive Mesenchymal Stromal Cells Derived from Human-Induced Pluripotent Stem Cells Induce Human Regulatory T Cells In Vitro and In Vivo
por: Roux, Clémence, et al.
Publicado: (2018)

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
por: Eguizabal, Cristina, et al.
Publicado: (2014)

Induced Pluripotent Stem Cells: Challenges and Opportunities for Cancer Immunotherapy
por: Sachamitr, Patty, et al.
Publicado: (2014)

Inherent Immunogenicity or Lack Thereof of Pluripotent Stem Cells: Implications for Cell Replacement Therapy
por: Chhabra, Arvind
Publicado: (2017)

Engineered Zinc Finger Protein Targeting 2LTR Inhibits HIV Integration in Hematopoietic Stem and Progenitor Cell-Derived Macrophages: In Vitro Study
por: Chupradit, Koollawat, et al.
Publicado: (2022)

Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
por: Galat, Vasiliy, et al.
Publicado: (2016)

Editorial: Advances in iPSC technology for disease modeling and therapeutic applications
por: Wattanapanitch, Methichit, et al.
Publicado: (2023)

Genetic correction of haemoglobin E in an immortalised haemoglobin E/beta-thalassaemia cell line using the CRISPR/Cas9 system
por: Trakarnsanga, Kongtana, et al.
Publicado: (2022)

Inhibition of complement activation by CD55 overexpression in human induced pluripotent stem cell derived kidney organoids
por: Gaykema, Lonneke H., et al.
Publicado: (2023)

Macrophages Derived From Human Induced Pluripotent Stem Cells Are Low-Activated “Naïve-Like” Cells Capable of Restricting Mycobacteria Growth
por: Nenasheva, Tatiana, et al.
Publicado: (2020)

The Emerging Role of Induced Pluripotent Stem Cells as Adoptive Cellular Immunotherapeutics
por: Mehra, Vedika, et al.
Publicado: (2023)

Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer
por: Bazargan, Sarah, et al.
Publicado: (2023)

Validation of Promoters and Codon Optimization on CRISPR/Cas9-Engineered Jurkat Cells Stably Expressing αRep4E3 for Interfering with HIV-1 Replication
por: Chupradit, Koollawat, et al.
Publicado: (2022)

Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E/β-thalassemia patient
por: Trakarnsanga, Kongtana, et al.
Publicado: (2020)

In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells
por: Nikolouli, Eirini, et al.
Publicado: (2022)

Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells
por: Kim, Huensuk, et al.
Publicado: (2018)

Recent Advances in Extracellular Vesicle-Based Therapies Using Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells
por: Bertolino, Giuliana Minani, et al.
Publicado: (2022)

The Use of Induced Pluripotent Stem Cells to Study the Effects of Adenosine Deaminase Deficiency on Human Neutrophil Development
por: Tsui, Michael, et al.
Publicado: (2021)

Preservation of Antigen-Specific Functions of αβ T Cells and B Cells Removed from Hematopoietic Stem Cell Transplants Suggests Their Use As an Alternative Cell Source for Advanced Manipulation and Adoptive Immunotherapy
por: Li Pira, Giuseppina, et al.
Publicado: (2017)

Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells
por: Dubonyte, Ugne, et al.
Publicado: (2022)

Role of T Cell Receptor Affinity in the Efficacy and Specificity of Adoptive T Cell Therapies
por: Stone, Jennifer D., et al.
Publicado: (2013)

Characterization of limbal explant sites: Optimization of stem cell outgrowth in in vitro culture
por: Ekpo, Pattama, et al.
Publicado: (2020)

Editorial: Implementing Logic Gates in Adoptive Cell Therapy
por: Gross, Gideon, et al.
Publicado: (2022)

Adoptive B cell therapy for chronic viral infection
por: Chung, Young Rock, et al.
Publicado: (2022)

Advances in Induced Pluripotent Stem Cell Technologies
por: Pal, Rajarshi, et al.
Publicado: (2012)

Induced pluripotent stem cells: advances to applications
por: Nelson, Timothy J, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_a1v0jt8255jdnos3uicr4bsj4v